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We have developed a mass spectrometry-based method that allows one to accurately
determine the glucose concentration of tear fluid. We used a 1 L micro-capillary to collect tear
fluid from the tear meniscus with minimal irritation of the eye. We analyzed the 1 L volume
of collected tear fluid with liquid-chromatography electrospray ionization mass spectrometry
with the use of D-glucose-6,6-d2 as an internal standard. Repeated measurements and a
recovery experiment on pooled, onion-induced tears showed that the analysis of the glucose
in tears was precise (4% relative standard deviation) and provided 100% recovery. We found
the tear glucose concentration of one fasting nondiabetic subject to be 13 to 51 M while the
onion-induced tear glucose concentration of a different nondiabetic subject to be 211 to 256
M. (J Am Soc Mass Spectrom 2007, 18, 332–336) © 2007 American Society for Mass
SpectrometryIn the United States, 9.6% of the population over20 y of age and 20.9% of the population over 60 yof age have Diabetes mellitus [1]. The Diabetes
Control and Complications Trial has shown that close
monitoring and tight control of blood glucose con-
centration is critical in preventing the complications
of diabetes [2]. Current self-monitoring methods rely
on invasive finger sticks to directly measure blood
glucose levels to provide the critical information
required to achieve glycemic control. A number of
noninvasive approaches to monitoring blood glucose
concentrations are being pursued; however, none
have been successfully developed to the point where
they have gained widespread clinical acceptance [3].
There has been significant recent activity in exploring
noninvasive monitoring by using tear fluid glucose as
an indicator for blood glucose [4 – 6]. Such an ap-
proach will be effective only if the glucose concentra-
tions in tear fluid are a reliable surrogate for blood
glucose concentrations.
A survey of the literature over the last 70 years on
tear glucose determinations indicates significant dis-
agreement in measured tear glucose concentrations and
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concentrations. Daum and Hill [7] noted in their 1982
review of the human tear glucose literature that re-
ported values of tear glucose in normal individuals
range between 0 and 3600 M with the median values
between 110 and 280 M. More recently, a study of six
nondiabetic adults found glucose concentrations in tear
fluid ranging between 128 and 166 M with an average
of 139 M [8].
The differences in tear glucose concentrations be-
tween these reports are likely due to the use of different
tear fluid collection methods. Van Haeringen and Gla-
sius specifically addressed the dependence of tear fluid
glucose on the method of collection [9]. They used a
glucose dehydrogenase method to analyze chemically
stimulated tears collected with a capillary and mechan-
ically stimulated tear fluid collected by filter paper. Van
Haeringen and Glasius found higher glucose concentra-
tions in the tear fluid collected by filter paper and
concluded that the increase is due to the mechanical
stimulation of the corneal and conjunctival epithelium
[9]. Other studies reported similar findings in experi-
ments on rabbits [10] and in subjects who were tested
immediately after swimming [7]. Therefore, it is appar-
ent that to determine a physiologically relevant, base-
line tear glucose concentration, tear fluid must be
acquired with minimal tear stimulation and eye irrita-
tion.
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333J Am Soc Mass Spectrom 2007, 18, 332–336 DETERMINATION OF GLUCOSE IN TEAR FLUIDSeveral previous studies used mass spectrometry to
analyze tears for constituents other than glucose. Fung
et al. [11] characterized the protein profile in the human
tear fluid with MALDI-ToF and electrospray ionization
mass spectrometry. Ham et al. [12] identified the lipid
profile in tear fluid and reported on their variations
between normal and dry eyes. There have been many
reports of glucose measurement by mass spectrometry
on bodily fluids other than tears. The majority of these
studies uses gas chromatography and an electron ion-
ization source [13–16]. With gas chromatography, glu-
cose typically needs to be derivatized to make it more
volatile. Other studies used liquid chromatography to
bypass the volatility issue [17, 18]. Sodium [19], lithium
[20, 21], cesium [17], and chloride [22] ions have been
used with electrospray ionization to form the cationic
adduct of glucose from aqueous solutions.
We discuss here a new, robust method of determin-
ing physiological tear glucose concentrations by using
electrospray ionization mass spectrometry (ESI-MS).
This method enables reliable studies of tear glucose
concentrations in tear fluid. We use a tear fluid sam-
pling method that is minimally irritating to the eye to
collect 1 L tear samples. We validate the ESI-MS
method by using glucose standard solutions, artificial
tear fluid, and large volumes of stimulated tears. We
determine tear glucose concentration in a nondiabetic,
fasting adult.
Experimental
All tear samples were collected and transferred with 1
L “Microcaps” micro-capillaries (Drummond Scien-
tific Co., Broomall, PA). The tear film meniscus on the
bottom eyelid was visualized using a slit lamp ophthal-
mic microscope (American Optics, Burlington, Canada).
The micro capillary was gently touched to this tear fluid
meniscus and the tear fluid was drawn in by capillary
action. During half the collections, there was inadequate
tear fluid to immediately fill the capillary with one
touch. In these cases, the subject was asked to blink to
redistribute the tear fluid and the capillary was again
touched to the meniscus. This process was repeated
until the capillary was completely filled. A few samples
required as many as five repetitions of this process.
Care was taken throughout tear fluid collection to avoid
stimulation of reflex tearing. The aqueous glucose stan-
dards were collected and transferred with the same
process as a tear sample; the capillary was touched to
the solution surface and was filled by capillary action.
For studies involving larger volumes of stimulated
tears, the subject chopped onions until tearing was
induced. These tears were collected by capillary action
with glass Pasteur pipettes (2 mL) and pooled for each
subject to analyze a homogeneous sample.
Immediately after collection, the tear sample was
transferred to a glass vial (Agilent, Palo Alto, CA) with
a glass insert (Restek, Bellafonte, PA) containing 10 L
of acetonitrile (Mallinckrodt Baker, Inc., Phillipsburg,NJ) and 10 L of an aqueous stock solution of isotopi-
cally labeled glucose (D-glucose-6,6-d2, 99% labeled,
Cambridge Isotope Laboratories, Andover, MA) used
as an internal standard. A typical value for the concen-
tration of the D-glucose-6,6-d2 stock solution was 27.5
M, corrected for the 99% labeling (leading to a D-glu-
cose-6,6-d2 concentration of 13.1 M in the sample
injected into the mass spectrometer). The vials were
then shaken and centrifuged for 5 min to ensure mixing
and that the liquid was collected at the bottom of the
vial. The samples were refrigerated at 5 °C until ana-
lyzed.
Glucose concentrations were measured using ESI-
MS. Samples were analyzed by flow injection analysis
on a HP 1000 LC-MS (Agilent). Initial studies used an
autosampler connected directly to the mass spec-
trometer. However, our optimized method used a 2
m filter and a Nova-Pak C18 3.9  150 mm column
(Waters, Milford, MA) placed between the autosam-
pler and the mass spectrometer. In both methods, the
mobile phase consisted of acetonitrile and water with
0.1% formic acid (Mallinckrodt Baker, Inc.) with a
constant flow rate of 0.2 mL/min. The ratio of water
to acetonitrile was 1:1 in the absence of the column
and 17:3 with the column. The ion chromatograms of
sodiated glucose isotopes (m/z 203 for natural glucose
and m/z 205 for D-glucose-6,6-d2) were selected from
the total ion chromatogram using the ChemStation
software Rev. A.06.03-[509]. These selected ion chro-
matograms were integrated to provide peak areas for
the two glucose signals. During integration, the soft-
ware option “baseline hold” was used. The peak
areas of m/z 203 and 205 were used to determine the
glucose-to-D-glucose-6,6-d2 ratio. When calculating
the peak area ratio, we took into account the 1.3%
m2 natural isotopic contribution of Na(glucose),
m/z 203, to m/z 205; 1.3% of the observed glucose peak
area of m/z 203 was subtracted from the observed m/z
205 peak area to determine the area due solely to the
internal standard. Each sample was injected three
times at 6.5 L per injection and the average glucose
concentration recorded. All human samples were
collected through protocols approved by the Univer-
sity of Pittsburgh Institutional Review Board.
Results and Discussion
The cationization of glucose with H, Na, K, or Pb2
was examined. An initial survey comparing negative
ion with positive ion ESI suggested greater promise
with positive ion methods. With the exception of so-
dium, millimolar concentrations of the acid or salt were
needed to observe the glucose cation adducts as the
base peak. The sodium-glucose adduct was present in
all of the spectra and, in the majority of them, was the
most abundant ion. Since sodiated glucose dominated
even without the addition of sodium and since tear
fluid contains 160 mM sodium [23], our glucose
analysis is based on the sodiated glucose ion. Further
.78 (R
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composition (water, acetonitrile, and methanol) that
provided the maximum signal for sodiated glucose.
Based on the results of these experiments, a 1:1 ratio of
water to acetonitrile for the sample solvent was se-
lected. For the experiments without the use of the
Nova-Pak C18 column, the 1:1 solvent ratio was also
used for the mobile phase with the addition of 0.1%
formic acid to the aqueous phase to produce more
stable baseline ion currents. In our initial work, 13C6-
glucose was used as an internal standard but an un-
identified peak at m/z 209 (which would interfere with
the detection of sodiated 13C6-glucose) was observed in
the absence of the internal standard. Therefore, D-glu-
cose-6,6-d2 was a superior alternative since no signal
was observed at m/z 205 in the absence of the internal
standard.
With the optimal solvents and internal standard
established, the effect of the biological matrix on the
glucose signal was examined. The sodiated glucose
signal intensity observed for both artificial and real tear
fluid was low compared with the background signal in
our initial studies in which samples were directly
infused into the mass spectrometer. Addition of a C18
column separated proteins, such as lysozyme, globulin,
and albumin, and excess salts from the elution time of
glucose. This in-line purification increased both the
sensitivity and signal-to-noise ratio for sodiated glu-
cose. Analysis of the blank (a protein-free, glucose-free
artificial tear solution [4] showed an average glucose
concentration of 0.98  0.56 M. With the use of the
Figure 1. Eleven spectra of aqueous solutions
intensities normalized to the internal standard D
regression of the experimental glucose conce
provided the best fit equation of y  0.99 x  0column the statistical limit of detection was lowered to3 M. These improvements occurred in the presence of
the column with the mobile phase optimized at a
solvent ratio of 17:3 of water with 0.1% formic acid to
acetonitrile which maximized the glucose signal and
minimized overlapping peaks.
The precision of the microcapillaries was measured
by gravimetric means. Five individual capillaries were
weighed, filled with water at 20 °C, and weighed again.
The average value for the water contained in the
capillaries was 1.008  0.013 mg (1.011  0.013 L at
20 °C). Therefore, in all of our analysis of tears we
assume a collection volume of 1.00 L.
To test the linearity of the method, aqueous solutions
with known glucose concentrations (0 to 200 M) were
prepared and analyzed. The linear regression of mea-
sured versus added glucose gave an equation of y 
0.99 x  0.78 (R2  0.98). The increase in the relative
sodiated glucose signal m/z 203 can be easily seen when
the mass spectra are normalized to the sodiated D-glu-
cose-6,6-d2 signal m/z 205 (Figure 1).
The mass spectral measurement over time of the
glucose concentration in the 1:1 ratio of water-to-aceto-
nitrile was examined. A 200 M glucose aqueous solu-
tion was prepared and sampled multiple times. These
vials were stored in a refrigerator and tested immedi-
ately, a few h later, 3 d later, and 1 wk later. The average
value for all of the samples was 201  15 M with no
increasing or decreasing trend over storage time (data
not shown).
The reproducibility of the method was determined
with the use of a pooled sample of onion-induced tears.
own glucose concentrations (0 to 200 M) with
ose-6,6-d2 signal intensity at m/z 205. The linear
ion versus the known glucose concentration
2  0.98).of kn
-gluc
ntratSix samples were collected from the pool and analyzed.
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this stimulated tear sample (data not shown).
A recovery experiment was performed on another
pooled sample of onion-induced tears. The tears were
spiked with aqueous glucose solutions to increase the
glucose concentration by 0, 107, 233, and 352 M. Linear
regression of measured versus added glucose gave an
equation of y  0.99 x  256 (R2  0.99) (Figure 2). We
also determined that the induced tear fluid contained
256 M glucose.
The average relative standard deviation over the
three 6.5 L injections of the diluted tear samples
studied with concentrations greater than 50 M glucose
was 4%. For the samples studied with concentrations
less than 50 M glucose, the average relative standard
deviation of the three measurements was 15%. The FDA
currently requires self-blood-glucose monitors to have
an accuracy of within 15%. Within one standard devi-
ation, the calibration curve is indistinguishable from y
 x and the recovery experiment shows 100% recovery
of added glucose. We therefore feel confident using
D-glucose-6,6-d2 as the internal standard and the y  x
calibration curve to determine tear glucose concentra-
tions.
We performed two studies on a nondiabetic subject
who fasted overnight. During both sessions, which
were separated by 1 wk, three samples were taken from
each eye. Samples from the same eye were collected at
10 min intervals. The tear glucose concentration from
this subject during the two sessions ranged from 13 to
51 M with an average of 32 M (Table 1). The
Figure 2. Duplicate samples of pooled, induc
glucose were analyzed. Error bars are  one
sample. Linear regression analysis gave an equa
range of 94 to 111% of the glucose spike.concentration of tear glucose determined in this workfor this nondiabetic subject is about 4-fold less than the
tear glucose concentrations recently reported [8].
Whereas previous studies used collection methods that
either touched the eye or chemically stimulated tears [7,
9, 10], we used glass micro-capillaries to collect a single
microliter volume of tear fluid from the tear meniscus
without touching the eye. This decrease in reported tear
glucose concentration is likely due to our less irritating
method of tear collection. The onion-stimulated tears
(from a different subject) showed a 7- to 8-fold higher
glucose concentration than in the absence of stimula-
tion.
Conclusions
In the present study, we demonstrate a robust ESI-MS
method for determining tear glucose concentration in
tear fluid. Liquid chromatography separates glucose
from the majority of salts and proteins, such as ly-
sozyme, globulin, and albumin, in tears reducing inter-
ference of the biological matrix on the sodiated-glucose
ears at four different concentrations of added
ard deviation from the average value of each
of y  0.99 x  256 (R2  0.99) and a recovery
Table 1. Tear glucose concentration of a nondiabetic subject
Sample
Session 1 Session 2
Left eye Right eye Left eye Right eye
1 22 38 44 48
2 51 37 50 25
3 13 17 14 24ed t
stand
tionNote: Concentrations are micromolar.
336 TAORMINA ET AL. J Am Soc Mass Spectrom 2007, 18, 332–336signal. The resulting increase in the sensitivity and
signal-to-noise ratio of glucose over data obtained with-
out the column allows measurements of tear glucose
concentrations as low as 10 M (limit of quantification)
by relying on an internal standard. We use a 1 L tear
sampling method that is minimally irritating to the eye.
This method enables reliable studies of physiological
tear glucose concentrations in nonstimulated tears. A
preliminary study indicates that the physiological, base-
line tear glucose concentration is substantially below
previous reports. Further studies are warranted to de-
termine the inter- and intra-individual variation in
baseline tear glucose concentration. This method will be
used to establish normal values for tear glucose concen-
tration and can monitor changes in tear glucose with
changes in blood glucose. Application of this LC-MS
method can help us to understand tear glucose physi-
ology. Our future work will determine whether moni-
toring tear glucose concentration is a viable approach
for noninvasive blood glucose monitoring. We are now
using this method for tear glucose concentration mea-
surements to examine a population of nondiabetic and
diabetic subjects to determine their tear fluid glucose
concentrations and their correlations of tear glucose
with blood glucose.
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